Cancer Archives

cancer top 8 biotech immunooncology europe oncology

News and Trends 7 Mar 2016

Infographic: The Top 8 Deadliest Cancers and Who in Biotech is Fighting Them

With more than 200 types of cancer, the possibility of developing a Universal Cure is in reality, a myth. However, the fight against the World’s Deadliest Cancers is far from being lost… Simply by having a quick look through our articles, we can easily confirm that cancer is one of the World’s main concerns in […]

March 7, 2016 - 2 minutesmins - By Dani Bancroft

leukemia mesothelioma myeloma sellas cancer immunoncology fda wt1

News and Trends 2 Mar 2016

Swiss Cancer Vaccine Gets 2 FDA Orphan Drug Designations

Sellas (Switzerland) is developing an immunotherapeutic cancer vaccine – which can be easier now that the FDA granted it Orphan Drug designations for two types of cancer (for the lung area and a type of leukemia). Sellas is a biopharma developing treatments for different cancers and diseases of the central nervous system (CNS). Its lead […]

March 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

win horizon centauri antibody avvinity cancer alphamer

News and Trends 2 Mar 2016

New Joint Venture to Shake Up Immuno-Oncology in the UK

Avvinity Therapeutics is the new child of two UK Biotechs: Horizon Discovery and Centauri. The goal? To create the ultimate immuno-oncology toolbox with€32M. Just created, Avvinity is a joint venture targeting the immuno-oncology field, which is worth around €32M – and is only expected to grow. The biotechnological approach to cancer treatments has many Pharma and Biotech companies interested, […]

March 2, 2016 - 3 minutesmins - By Denise Neves Gameiro

exelixis ipsen cancercabozantinib renal liver endometrial nsclc

News and Trends 1 Mar 2016

French Ipsen closes €700M deal for Californian Cancer Drug

Ipsen is paying Exelixis $200M upfront, plus $545M in future milestones to acquire commercialization rights for a multi-organ cancer candidate outside US, Canada and Japan. California-based Exelixis has found an European partner to license the small molecule drug, cabozantinib. Ipsen, a French biotech group, will have comercialization rights for cabozantinib worldwide, except in the US and […]

March 1, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 24 Feb 2016

German Biotech wins FDA Approval for New Liver Cancer Trial

4SC, in Germany, has the FDA’s green light to conduct efficacy trials in the US with a candidate drug against hepatocellular carcinoma. Munich-based 4SC’s lead candidate, resminostat, is a small-molecule being tested in several trials for some of the deadliest cancers. These include liver – which is also known as hepatocellular carcinoma (HCC). Resminostat is an inhibitor of histone […]

February 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

desktop genetics gene ngs illumina epigenetics

News and Trends 23 Feb 2016

UK Start-Up Gets €380k to Understand Cancer with CRISPR

Desktop Genetics, a small bioinformatics start-up out of London, has won a substantial grant to understand why some cancer cells just won’t quit. To do this, it relies on CRISPR, their expertise with genetic data, and research from Imperial College London. Desktop Genetics has already proven that it can move some money, with a €1.87 […]

February 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 22 Feb 2016

Making Bladder Cancer Cells Glow earns French Biotech €1.5M

VitaDX (France), is developing a non-invasive medical device for early detection of bladder cancer, based on a syndicate of French academic research. This simple urine sample analysis has attracted over €1.5M in preparation for clinical trials and a global market launch. The technology operated by VitaDX is the result of a research collaboration between the Institute of Molecular […]

February 22, 2016 - 3 minutesmins - By Dani Bancroft

onxeo cancer beleodaq interview Judith Greciet

News and Trends 22 Feb 2016

Meet the CEO of a Confident Orphan Oncology Biotech from France & Denmark

Last week, I was in Paris to meet with one of our Investors, during which time I also had a chance to visit the French Cancer Biotech, Onxeo. I met with the CEO of Onxeo, Judith Greciet, who was confident about the future of the company. She moved into the role in 2011 after having spent […]

February 22, 2016 - 4 minutesmins - By Philip Hemme

DIRK BUSCH TECHNICAL UNIVERSITY MUNICH car t leukemia all

News and Trends 17 Feb 2016

Cancer: World Best Ever CAR-T Results have Just been Disclosed

These are the best results yet for CAR-T, this time from a research group led by Dirk Busch at the Technical University of Munich (Germany). In part backed by Juno Therapeutics, a method to select more potent T-cells and engineer a safety mechanism was announced at the annual meeting of the AAAS in Washington (US). CAR-T therapies are one of the ways […]

February 17, 2016 - 3 minutesmins - By Denise Neves Gameiro

apogenix glioblastoma cancermark german apg101

News and Trends 17 Feb 2016

Brain Cancer Biomarker is a Magnet for Public Money in Germany

Apogenix (Germany) has been granted €3M for a personalized medicine to treat glioblastoma. It will also use this funding to develop a companion diagnostic test using a specific cancer biomarker, which other German biotechs are also attempting to do… This Heidelberg based-biotech (which we visited on our Labiotech tour of South Germany) is focused on the development of protein Immuno-Oncology therapeutics to treat […]

February 17, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 16 Feb 2016

This Swiss Bioinformatics Start-Up is Simplifying NGS and Data Driven Medicine for Hospitals

As one of the most successful medical bioinformatics start-ups in Europe, Sophia Genetics (Switzerland) has now forged a partnership with a US nucleic acid synthesis company to facilitate the transition to Data Driven Medicine. This Swiss start-up led the way in European medical informatics when their software earned accreditation to store patient genomic data – a true […]

February 16, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 12 Feb 2016

Biotech of the week: Nordic Nanovector & its ARC technology

This week we say ‘au revoir’ to Nantes and head back up to the Scandinavian country that is Norway, in particular it’s capital city, Oslo – the location of our biotech of the week, Nordic Nanovector. City: Oslo, Norway Founded: 2009 Employees: +/- 30 (as off 11/15) Financial Data: €156M Market Cap (on 23/11/2015) CEO: Missions: Betalutin, a potential new treatment […]

February 12, 2016 - 1 minutemin - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cancer

Infographic: The Top 8 Deadliest Cancers and Who in Biotech is Fighting Them

Swiss Cancer Vaccine Gets 2 FDA Orphan Drug Designations

New Joint Venture to Shake Up Immuno-Oncology in the UK

French Ipsen closes €700M deal for Californian Cancer Drug

German Biotech wins FDA Approval for New Liver Cancer Trial

UK Start-Up Gets €380k to Understand Cancer with CRISPR

Making Bladder Cancer Cells Glow earns French Biotech €1.5M

Meet the CEO of a Confident Orphan Oncology Biotech from France & Denmark

Cancer: World Best Ever CAR-T Results have Just been Disclosed

Brain Cancer Biomarker is a Magnet for Public Money in Germany

This Swiss Bioinformatics Start-Up is Simplifying NGS and Data Driven Medicine for Hospitals

Biotech of the week: Nordic Nanovector & its ARC technology

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!